The carcinogenic action of crystalline silica: a review of the evidence supporting secondary inflammation-driven genotoxicity as a principal mechanism.

Authors:
Lang Tran
Lang Tran
University Park
United Kingdom
Ken Donaldson
Ken Donaldson
University of Edinburgh
United Kingdom

Crit Rev Toxicol 2011 Oct;41(9):756-70

Centre of Expertise in Life Sciences, Zuyd University, Heerlen, The Netherlands.

In 1987 the International Agency for Research on Cancer (IARC) classified crystalline silica (CS) as a probable carcinogen and in 1997 reclassified it as a Group 1 carcinogen, i.e., that there was sufficient evidence for carcinogenicity in experimental animals and sufficient evidence for carcinogenicity in humans. The Working Group noted that "carcinogenicity in humans was not detected in all industrial circumstances studied, carcinogenicity may be dependent on inherent characteristics of the crystalline silica or on external factors affecting its biological activity or distribution of its polymorphs." This unusual statement that the physicochemical form of the CS influences its carcinogenicity is well understood at the toxicological level and arises as a consequence of the fact that CS activity depends on the reactivity of the CS surface, which can be blocked by a number of agents. We reviewed the literature on CS genotoxicity that has been published since the 1997 monograph, with special reference to the mechanism of CS genotoxicity. The mechanism of CS genotoxicity can be primary, a result of direct interaction of CS with target cells, or indirect, as a consequence of inflammation elicited by quartz, where the inflammatory cell-derived oxidants cause the genotoxicity. The review revealed a number of papers supporting the hypothesis that the CS genotoxic and inflammatory hazard is a variable one. In an attempt to attain a quantitative basis for the potential mechanism, we carried out analysis of published data and noted a 5-fold greater dose required to reach a threshold for genotoxic effects than for proinflammatory effects in the same cell line in vitro. When we related the calculated threshold dose at the proximal alveolar region for inflammation in a published study with the threshold dose for genotoxicity in vitro, we noted that a 60-120-fold greater dose was required for direct genotoxic effects in vitro. These data strongly suggests that inflammation is the driving force for genotoxicity and that primary genotoxicity of deposited CS would play a role only at very high, possibly implausible, exposures and deposited doses. Although based on rat studies and in vitro studies, and therefore with caveats, the analysis supports the hypothesis that the mechanism of CS genotoxicity is via inflammation-driven secondary genotoxicity. This may have implications for setting of the CS standard in workplaces. During the writing of this review (in May 2009), IARC undertook a review of carcinogenic substances, including CS. The Working Group met to reassess 10 separate agents including CS. This was not a normal monograph working group published as a large single monograph, but was published as a two-page report. This review group reaffirmed the carcinogenicity of "silica dust, crystalline in the form of quartz or cristobalite" as a Group 1 agent, with the lung as the sole tumor site. Of special relevance to the present review is that the cited "established mechanism events" for CS are restricted to the words "impaired particle clearance leading to macrophage activation and persistent inflammation." The lack of mention of direct genotoxicity is in line with the conclusions reached in the present review.

Download full-text PDF

Source
http://dx.doi.org/10.3109/10408444.2011.576008DOI Listing
October 2011
8 Reads

Publication Analysis

Top Keywords

crystalline silica
12
working group
12
mechanism genotoxicity
12
genotoxicity
11
genotoxicity primary
8
genotoxic effects
8
dose required
8
greater dose
8
sufficient evidence
8
evidence carcinogenicity
8
threshold dose
8
review
7
group
6
mechanism
6
carcinogenicity
5
published
5
dose genotoxicity
4
vitro 60-120-fold
4
genotoxicity vitro
4
inflammation published
4

Similar Publications

Inhaled amorphous silica particulates: what do we know about their toxicological profiles?

Authors:
D B Warheit

J Environ Pathol Toxicol Oncol 2001 ;20 Suppl 1:133-41

DuPont Haskell Laboratory, Newark, DE 19714-0050, USA.

The International Agency for Research on Cancer (IARC) recently published a monograph on the evaluation of carcinogenic risks to humans of exposure to crystalline and amorphous silica particles. The IARC Working Group concluded that crystalline silica, in the form of quartz or cristobalite, from occupational sources posed a carcinogenic risk to humans (Category 1). IARC also determined that amorphous silica particles were not classifiable as to its carcinogenicity to humans (Category 3). Read More

View Article
October 2001

In vitro comet and micronucleus assays do not predict morphological transforming effects of silica particles in Syrian Hamster Embryo cells.

Mutat Res Genet Toxicol Environ Mutagen 2016 Jan 27;796:23-33. Epub 2015 Nov 27.

Département Toxicologie et Biométrologie, Institut National de Recherche et de Sécurité (INRS), Rue du Morvan, CS 60027, 54519 Vandoeuvre Les Nancy Cedex, France.

Crystalline silica particles and asbestos have both been classified as carcinogenic by the International Agency for Research on Cancer (IARC). However, because of the limited data available, amorphous silica was not classifiable. In vitro, the carcinogenic potential of natural crystalline and amorphous silica particles has been revealed by the Syrian Hamster Embryo (SHE) cell transformation assay. Read More

View Article
January 2016

An updated review of the genotoxicity of respirable crystalline silica.

Part Fibre Toxicol 2018 05 21;15(1):23. Epub 2018 May 21.

Kirkland Consulting, Tadcaster, UK.

Human exposure to (certain forms of) crystalline silica (CS) potentially results in adverse effects on human health. Since 1997 IARC has classified CS as a Group 1 carcinogen [1], which was confirmed in a later review in 2012 [2]. The genotoxic potential and mode of genotoxic action of CS was not conclusive in either of the IARC reviews, although a proposal for mode of actions was made in an extensive review of the genotoxicity of CS by Borm, Tran and Donaldson in 2011 [3]. Read More

View Article
May 2018

Bioreactivity of the crystalline silica polymorphs, quartz and cristobalite, and implications for occupational exposure limits (OELs).

Crit Rev Toxicol 2013 Sep 18;43(8):632-60. Epub 2013 Jul 18.

Department of Pathology, University of Vermont College of Medicine, Burlington, VT 05405-0068, USA.

Silica or silicon dioxides (SiO₂) are naturally occurring substances that comprise the vast majority of the earth's crust. Because of their prevalence and commercial applications, they have been widely studied for their potential to induce pulmonary fibrosis and other disorders. Historically, the focus in the workplace has been on the development of inflammation and fibrotic lung disease, the basis for promulgating workplace standards to protect workers. Read More

View Article
September 2013